Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.66 USD | +4.45% | +3.54% | 0.00% |
Business Summary
Number of employees: 31
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel, Oral Small Molecule Therapies for Neuroscience, Inflammation and Immunology Indications
100.0
%
| 0 | nan % | 50 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 50 | 100.0 % | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,729,172 | 0 | 0 | 65.58 % |
Stock B | 1 | 18,994,104 | 16,869,868 ( 88.82 %) | 0 |
Company contact information
Pipeline Therapeutics, Inc.
10578 Science Center Drive Suite 200
92121, San Diego
+
http://www.contineum-tx.comSector
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 410M | |
+48.54% | 56.87B | |
+37.15% | 39.72B | |
-6.02% | 39.27B | |
-6.90% | 28.73B | |
+12.97% | 26.21B | |
-16.91% | 19.79B | |
+31.71% | 12.28B | |
+28.18% | 12.23B | |
+0.38% | 12.12B |
- Stock Market
- Equities
- CTNM Stock
- Company Contineum Therapeutics, Inc.